µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© j`K0D65
fwh/#V-i
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 2|U6dLZ!
1¡¢Co-stimulators (or co-stimulating molecules) J25/Iy*byG
2¡¢NK-kB %!A-K1Z\D
3¡¢Immunoglobulin superfamily ^(@]5$^Z
4¡¢antigen-presenting cell (APC) (f~}5O<
5¡¢death domain
kKY,&Fn-
6¡¢CCR and CXCR k~F,n
7¡¢Lectin (or mitogen) [xQ.qZ[h&
8¡¢Clusters of differentiation, CD) ^NM>xIenf
9¡¢B7 family B~J63Os/
10¡¢Cytotoxic T lymphocyte, CTL) Dz/MIx
11¡¢IL-15 and IL-15 receptor (IL-15R) ZwiXeD+4
12¡¢MHC restriction .ud&$-[a
13¡¢Affinity-chromatography mS49l
14¡¢Cyctosprin A, CsA N P5K1:
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) ?FEh9l)d\
B}K<L\S
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© FMzG6nrdBN
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 e AaS }g
0
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ '(ZT}N
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ JNP6qM
Hw62'%
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© 2MW7nIEs
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ dP>FXgY
ѪҺ²¡Ñ§×¨Òµ£º #
@7
I
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿